November 19, 2025 a 08:39 am
IQV: Analysts Ratings - IQVIA Holdings Inc.
IQVIA Holdings Inc. has shown a mixed analyst sentiment in recent months. With its diverse offerings in analytics, technology, and clinical research for the life sciences industry, analysts have varied in their recommendations. Currently, there is a trend towards moderate confidence with a decrease in aggressive buy recommendations compared to historical data. The company's strategic direction and financial performance continue to be pivotal in shaping these analyst perspectives.
Historical Stock Grades
The analyst ratings for IQVIA Holdings Inc. for November 2025 reflect a balanced yet conservative sentiment. The distribution of recommendations indicates a predominant 'Buy' stance, with a slight decrease in 'Strong Buy' endorsements compared to previous months. Visualizing these recommendations helps in understanding the prevailing analyst perspective.
| Recommendation | Number | Score Bar |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 16 | |
| Hold | 5 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Over the last several months, the sentiment towards IQVIA’s stock has shown a gradual decline in strong buy ratings, while hold recommendations have seen a slight increase. The overall number of recommendations has remained relatively stable, suggesting a consistent analyst engagement.
- The number of 'Strong Buy' ratings peaked in March 2025 with seven recommendations but has since decreased.
- 'Buy' ratings have fluctuated minimally, indicating steady analyst confidence.
- 'Hold' ratings have seen a slight upward trend, reflecting a cautious approach.
Percentage Trends
Analyzing percentage trends of analyst recommendations reveals subtle shifts in confidence levels. November 2025 data shows a continuation of decreased strong buy recommendations while maintaining a robust buy sentiment.
- The proportion of 'Buy' ratings has consistently been high, accounting for approximately 62% in recent months.
- 'Strong Buy' ratings have dropped from earlier highs, now at around 12% of total recommendations.
- 'Hold' ratings hover around 19%, signifying increased caution among analysts.
- No 'Sell' or 'Strong Sell' recommendations indicate no significant bearish outlook at present.
Latest Analyst Recommendations
Recent updates in analyst recommendations for IQVIA Holdings Inc. show slight variations in opinion, with some downgrades indicating a more conservative stance.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-03 | Hold | Buy | TD Cowen |
| 2025-10-29 | Buy | Buy | UBS |
| 2025-10-29 | Buy | Buy | Truist Securities |
| 2025-10-29 | Buy | Buy | Stifel |
| 2025-10-29 | Overweight | Overweight | JP Morgan |
Analyst Recommendations with Change of Opinion
Analyzing recommendations with opinion changes provides insights into shifting analyst sentiment and market perception adjustments.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-03 | Hold | Buy | TD Cowen |
| 2025-10-29 | Outperform | Neutral | Baird |
| 2025-10-09 | Buy | Hold | HSBC |
| 2025-09-09 | Buy | Hold | Jefferies |
| 2025-04-25 | Hold | Buy | HSBC |
Interpretation
The current analyst sentiment towards IQVIA Holdings Inc. suggests a stable market outlook, though with elements of caution. The prevailing moderate buy recommendations paired with a rise in hold categories imply balanced expectations amidst market uncertainties. While there appears no significant bearish sentiment, the decline in strong buy endorsements suggests analysts are awaiting further data or events to justify stronger bullish positions.
Conclusion
In conclusion, IQVIA Holdings Inc. maintains a promising position within its industry, supported by a solid if cautious analyst outlook. The company's diverse portfolio in life sciences analytics and solutions continues to attract buy recommendations, indicating underlying confidence. Nevertheless, a slight shift towards hold ratings points to uncertainties, either in market conditions or company-specific performance. Going forward, expanding market insights or strategic pivots might influence future analyst opinions significantly.